Inflammatory responses induced by poly-L-arginine in rat lungs in vivo.
The inflammatory responses induced by the synthetic polycation poly-L-arginine injected either into the pleural cavity or into the trachea in rats have been investigated. Poly-L-arginine (4-40 nmol/rat) injected intrapleurally induced exudate formation and leucocyte migration (mainly polymorphonuclear cells). The exudate formation (but not cell migration) was dependent on the molecular weight of the poly-L-arginine used (24 and 115 kD). The poly-L-arginine-induced pleurisy was mainly dependent on activation of mast cells since it was significantly reduced either in rats depleted of their stores of histamine and serotonin or in rats previously treated with the serotonin receptor antagonist methysergide. The polyanions heparin and dermatan sulphate when administered intrapleurally with the polycation markedly reduced the exudate formation. Poly-L-arginine (115 kD, 8.5 nmol/rat) injected intratracheally caused lung oedema, increased leucocyte number and protein content of bronchoalveolar lavage, respiratory insufficiency and 60% mortality in 6 h. Depletion of histamine and serotonin stores or of circulating neutrophils decreased the leucocytes in bronchoalveolar lavage but did not increase survival rate, whereas the polyanion dermatan sulphate prevented the mortality completely. These results suggest that the inflammatory changes caused by poly-L-arginine are dependent on mast cell activation but that the lethality after intratracheal administration is due to electrostatic interactions of the polycation with anionic surfaces present in the pulmonary epithelium.
Santana
A
A
Department of Pharmacology, Faculty of Medical Sciences, UNICAMP, Brazil.
Hyslop
S
S
Antunes
E
E
Mariano
M
M
Bakhle
Y S
YS
de Nucci
G
G
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D005122:Exudates and Transudates / Q000166:cytology / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006632:Histamine / Q000378:metabolism; D007267:Injections; D007958:Leukocyte Count; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D009504:Neutrophils / Q000378:metabolism; D010455:Peptides / Q000008:administration & dosage / Q000633:toxicity*; D010994:Pleura; D011014:Pneumonia / Q000139:chemically induced*; D011506:Proteins / Q000378:metabolism; D011654:Pulmonary Edema / Q000139:chemically induced / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000378:metabolism; D014132:Trachea
D010455:Peptides; D011506:Proteins; C015462:polyarginine; D012701:Serotonin; D006632:Histamine; D006493:Heparin